Dietary oxidized linoleic acid lowers triglycerides via APOA5/APOClll dependent mechanisms.
Previously we have shown that intestinal cells efficiently take up oxidized fatty acids (OxFAs) and that atherosclerosis is increased when animals are fed a high cholesterol diet in the presence of oxidized linoleic acid. Interestingly, we found that in the absence of dietary cholesterol, the oxidized fatty acid fed low-density lipoprotein (LDL) receptor negative mice appeared to have lower plasma triglyceride (TG) levels as compared to animals fed oleic acid. In the present study, we fed C57BL6 mice a normal mice diet supplemented with oleic acid or oxidized linoleic acid (at 18 mg/animal/day) for 2 weeks. After the mice were sacrificed, we measured the plasma lipids and collected livers for the isolation of RNA. The results showed that while there were no significant changes in the levels of total cholesterol and high-density lipoprotein cholesterol (HDLc), there was a significant decrease (41.14%) in the levels of plasma TG in the mice that were fed oxidized fatty acids. The decreases in plasma TG levels were accompanied by significant increases (P<0.001) in the expressions of APOA5 and acetyl-CoA oxidase genes as well as a significant (P<0.04) decrease in APOClll gene expression. Oxidized lipids have been suggested to be ligands for peroxisome proliferator-activated receptor (PPAR*). However, there were no increases in the mRNA or protein levels of PPAR* in the oxidized linoleic acid fed animals. These results suggest that oxidized fatty acids may act through an APOA5/APOClll mechanism that contributes to lowering of TG levels other than PPAR* induction.
Garelnabi
Mahdi
M
Division of Cardiothoracic Surgery, N-850 Doan Hall, 410 W 10th Avenue, Ohio State University, Columbus, OH 43210-1292, USA.
Selvarajan
Krithika
K
Litvinov
Dmitry
D
Santanam
Nalini
N
Parthasarathy
Sampath
S
D000818:Animals; D000072040:Apolipoprotein A-V; D053305:Apolipoprotein C-III / Q000378:metabolism*; D001053:Apolipoproteins / Q000235:genetics* / Q000378:metabolism*; D050197:Atherosclerosis / Q000378:metabolism; D002784:Cholesterol / Q000378:metabolism; D004032:Diet; D005227:Fatty Acids / Q000378:metabolism; D007249:Inflammation; D019787:Linoleic Acid / Q000378:metabolism / Q000494:pharmacology*; D008297:Male; D051379:Mice; D008810:Mice, Inbred C57BL; D010100:Oxygen / Q000737:chemistry; D047493:PPAR alpha / Q000378:metabolism; D014280:Triglycerides / Q000378:metabolism*
C499058:Apoa5 protein, mouse; D000072040:Apolipoprotein A-V; D053305:Apolipoprotein C-III; D001053:Apolipoproteins; D005227:Fatty Acids; D047493:PPAR alpha; D014280:Triglycerides; D002784:Cholesterol; D019787:Linoleic Acid; D010100:Oxygen